Trial Summary
What is the purpose of this trial?This study is designed to identify brain activity associated with good memory in subjects with a chronically implanted RNS® device and to study the effects of therapeutic stimulation for epilepsy on memory. This will be accomplished through analysis of ECoG data collected during memory encoding for short and long-term free recall as well as during navigation tasks.
Eligibility Criteria
This trial is for adults over 18 with epilepsy who have had an RNS® device implanted for at least 3 months. Participants must be able to consent and complete tasks as judged by the lead researcher.Inclusion Criteria
I am 18 years old or older.
I have been diagnosed with epilepsy.
I have an RNS device for my epilepsy.
Treatment Details
The study examines how brain activity linked to good memory functions in people with epilepsy using ECoG data from those with an RNS® device during memory and navigation tasks.
1Treatment groups
Experimental Treatment
Group I: RNS® NeurostimulatorExperimental Treatment1 Intervention
Subjects with pharmaceutically intractable seizures who have been implanted with a RNS® Neurostimulator.
Electrical Stimulation is already approved in United States, European Union, Canada for the following indications:
🇺🇸 Approved in United States as Electrical Stimulation for:
- Pain relief
- Muscle strengthening
- Rehabilitation after injury or surgery
- Neurological disorders
- Wound healing
🇪🇺 Approved in European Union as Electrical Stimulation for:
- Pain management
- Muscle rehabilitation
- Neurological conditions
- Wound care
🇨🇦 Approved in Canada as Electrical Stimulation for:
- Chronic pain
- Muscle atrophy
- Neurological rehabilitation
- Wound healing
Find a clinic near you
Research locations nearbySelect from list below to view details:
Dartmouth-Hitchcock Medical Center in Lebanon, NHLebanon, NH
Loading ...
Who is running the clinical trial?
Barbara JobstLead Sponsor
NeuroPaceIndustry Sponsor